Anonymous ID: 604695 Feb. 1, 2019, 1:18 p.m. No.4992176   🗄️.is 🔗kun

There have been NO insider sales here since February '17

 

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of orally administered small molecule drug candidates. Its drug candidate for the treatment of Alzheimer's disease (AD) is azeliragon (TTP488), an orally administered, small molecule antagonist targeting the receptor for advanced glycation endproducts (RAGE), for which it has commenced patient enrollment in a Phase III clinical trial. Its type II diabetes drug candidates include TTP399, an orally administered, liver-selective glucokinase activator (GKA), for which it has completed enrollment in its Phase IIb clinical trial, and TTP273, an orally administered, non-peptide agonist that targets the glucagon-like peptide-1 receptor (GLP-1r), for which it began enrollment in a Phase II clinical trial. It has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders.

 

https://www.marketscreener.com/VTV-THERAPEUTICS-INC-23175037/company/

 

https://www.secform4.com/insider-trading/1641489.htm

Anonymous ID: 604695 Feb. 1, 2019, 1:27 p.m. No.4992281   🗄️.is 🔗kun

DOW

Volume 371,062,233

Avg. Volume 369,142,295

Just above and the last few ticks of say pushed it there.

 

NAS

Volume 2,134,187,729

Avg. Volume 2,402,656,229

better but still below

 

SP500*

Volume 2,425,612,408

Avg. Volume 3,999,857,540

 

*Continues to be well below daily averages

 

AMZN closed on LOD and no help into the close.

 

DOW, NAS, SP500 all got the routine spray job at the close with the highest volumes on the day for all three.

Caps are NAS and DOW

Anonymous ID: 604695 Feb. 1, 2019, 1:44 p.m. No.4992479   🗄️.is 🔗kun

It was authorized shortly after the Nov. '16 election by the BOD

 

https://www.businessinsider.com/microsoft-40-billion-buyback-and-share-repurchase-2016-9